Shirin Abbasinejad Enger

Shirin Abbasinejad Enger

Auto-generated profile, based on publicly available information

Shirin Abbasinejad Enger

McGill University

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Seminars in Radiation Oncology
Verified
Journal Article
Closed access
SEShirin A. Enger
Shirin A. Enger
JVJavier Vijande
Javier Vijande
MRMark J. Rivard
Mark J. Rivard

1 May 2017 in Brachytherapy
Verified
Journal Article
Closed access
JDJ. DeCunha
J. DeCunha
CJC. Janicki
C. Janicki
SES.A. Enger
S.A. Enger

23 May 2023 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
FBFrancisco Berumen
Francisco Berumen
SEShirin A Enger
Shirin A Enger
LBLuc Beaulieu
Luc Beaulieu
Objective. The Monte Carlo (MC) method provides a complete solution to the tissue heterogeneity effects in low-energy low-dose rate (LDR) brachytherapy. However, long computation times limit the clinical implementation of MC-based treatment planning solutions. This work aims to apply deep learning (DL) methods, specifically a model trained with MC simulations, to predict accurate dose to medium in medium (D M,M) distributions in LDR prostate brachytherapy. Approach. To train the DL model, 2369 single-seed configurations, corresponding to 44 prostate patient plans, were used. These patients underwent LDR brachytherapy treatments in which 125I SelectSeed sources were implanted. For each seed configuration, the patient geometry, the MC dose volume and the single-seed plan volume were used to train a 3D Unet convolutional neural network. Previous knowledge was included in the network as an r 2 kernel related to the first-order dose dependency in brachytherapy. MC and DL dose distributions were compared through the dose maps, isodose lines, and dose-volume histograms. Features enclosed in the model were visualized. Main results. Model features started from the symmetrical kernel and finalized with an anisotropic representation that considered the patient organs and their interfaces, the source position, and the low- and high-dose regions. For a full prostate patient, small differences were seen below the 20% isodose line. When comparing DL-based and MC-based calculations, the predicted CTV D 90 metric had an average difference of −0.1%. Average differences for OARs were −1.3%, 0.07%, and 4.9% for the rectum D 2cc, the bladder D 2cc, and the urethra D 0.1cc. The model took 1.8 ms to predict a complete 3D D M,M volume (1.18 M voxels). Significance. The proposed DL model stands for a simple and fast engine which includes prior physics knowledge of the problem. Such an engine considers the anisotropy of a brachytherapy source and the patient tissue composition.

4 October 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Te VuongTe Vuong
Te Vuong
AGAurelie Garant
Aurelie Garant
VVVéronique Vendrely
Véronique Vendrely
RNRemi Nout
Remi Nout
AMAndre-Guy Martin
Andre-Guy Martin
SDSlobodan Devic
Slobodan Devic
(1) Background: The introduction of total mesorectal excision (TME) for rectal cancer has led to improvement in local recurrence (LR) outcomes. Furthermore, the addition of preoperative external beam radiotherapy to TME reduces LR to less than 6%. As a trade-off to these gradual improvements in local therapies, the oncology community’s work is now focusing on mitigating treatment-related toxicities. In other words, if a small proportion of 4–6% of rectal cancer patients benefit from additional local therapy beyond TME, the burden of acute and long-term side effects must be considered with care. (2) Methods: With the introduction of better-quality imaging for tumor visualization and treatment planning, a new conformed radiation treatment was introduced with high-dose-rate endorectal brachytherapy. The treatment concept was tested in phase I and II studies: first in the pre-operative setting, and then as a boost after external beam radiation therapy, as a dose-escalation study, to achieve higher local tumor control. (3) Results: HDREBT is safe and effective in achieving a high tumor regression rate and was well tolerated in a phase II multicenter and two matched-pair studies. (4) Conclusions: HDREBT is a conformed radiation therapy that is safe and effective, and is presently explored in a phase III dose-escalation study in the NOM of patients with operable rectal cancer.

9 November 2022 in Medical Physics
Verified
Journal Article
Open access
LCLiam Carroll
Liam Carroll
SEShirin A. Enger
Shirin A. Enger
Background: Dynamic positron emission tomography (dPET) is a nuclear medicine imaging technique providing functional images for organs of interest with applications in oncology, cardiology, and drug discovery. This technique requires the acquisition of the time‐course arterial plasma activity concentration, called the arterial input function (AIF), which is conventionally acquired via arterial blood sampling.Purpose: The aim of this study was to (A) optimize the geometry for a novel and cost efficient non‐invasive detector called NID designed to measure the AIF for dPET scans through Monte Carlo simulations and (B) develop a clinical data analysis chain to successfully separate the arterial component of a simulated AIF signal from the venous component.Methods: The NID was optimized by using an in‐house Geant4‐based software package. The sensitive volume of the NID consists of a band of 10 cm long and 1 mm in diameter scintillating fibers placed over a wrist phantom. The phantom was simulated as a cylinder, 10 cm long and 6.413 cm in diameter comprised of polyethylene with two holes placed through it to simulate the patient's radial artery and vein. This phantom design was chosen to match the wrist phantom used in our previous proof of concept work. Two geometries were simulated with different arrangements of scintillating fibers. The first design used a single layer of 64 fibers. The second used two layers, an inner layer with 29 fibers and an outer layer with 30 fibers. Four positron emitting radioisotopes were simulated:18F,11C,15O, and68Ga with 100 million simulated decay events per run. The total and intrinsic efficiencies of both designs were calculated as well as the full width half maximum (FWHM) of the signal. In addition, contribution by the annihilation photons versus positrons to the signal was investigated. The results obtained from the two simulated detector models were compared. A clinical data analysis chain using an expectation maximization maximum likelihood algorithm was tested. This analysis chain will be used to separate arterial counts from the total signal.Results: The second NID design with two layers of scintillating fibers had a higher efficiency for all simulations with a maximum increase of 17% total efficiency for11C simulation. All simulations had a significant annihilation photon contribution. The signal for18F and11C was almost entirely due to photons. The clinical data analysis chain was within 1% of the true value for 434 out of 440 trials. Further experimental studies to validate these simulations will be required.Conclusions: The design of the NID was optimized and its efficiency increased through Monte Carlo simulations. A clinical data analysis chain was successfully developed to separate the arterial component of an AIF signal from the venous component. The simulations show that the NID can be used to accurately measure the AIF non‐invasively for dPET scans.

1 November 2019 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Open access
WSWilliam Song
William Song
SEShirin A. Enger
Shirin A. Enger